Key Points
- This research addresses issues related to the laboratory monitoring of heparin dosage and its implications for treatment outcomes.
- Evaluated the effects of different anticoagulant cocktails on APTT in blood samples from patients on heparin therapy.
- Collaborated various blood sampling techniques for monitoring heparin levels and their impact on clotting time.
- Assessed the relationship between heparin dosages and activated partial thromboplastin time (APTT) results across different settings.
- Samples collected using citrate showed APTT prolongation of approximately 10% compared to CTAD (citrate, theophylline, adenosine, dipyridamole) samples.
- Heparin neutralization was significantly reduced using CTAD, with APTTs showing a reduction of less than 11%.
- Diurnal variations in APTT demonstrated differences of up to 60% between night and day measurements.
Structured PICO
IInterventionLaboratory monitoring of unfractionated heparin dosage using activated partial thromboplastin time (APTT)
Accurate heparin monitoring requires strict control of pre-analytical variables like tube type, citrate concentration, and processing time due to the high variability of APTT assays.